mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |